Business Insights Research Reports

Title	Published	Price
R&D Cost Cutting: Managing cost containment and safeguarding productivity By: Business Insights Report Overview In recent years, drug developers have been under significant pressure to introduce new products while confronting escalating R&D costs, blockbuster patent expirations and heightened regulatory scrutiny. The current global economic climate has now intensified \| more... Search inside this report	4/21/2009	$3,835.00
Emerging IPTV and Mobile TV Models: Market opportunities, challenges and key vendors By: Business Insights The delivery of TV is undergoing one of the biggest transformations in its history, driven by technological innovation and changing consumer habits. Over the next few years, the entire broadcast market will make the transition \| more... Search inside this report	4/20/2009	$2,875.00
The Top 10 Biosimilar Players: Positioning, performance and SWOT analyses By: Business Insights Biologics continue to outperform the global pharma market, driven by premium priced therapies for conditions that cannot be managed by conventional drugs. The rapid penetration of novel biologics and the gradual expiry of their patents \| more... Search inside this report	4/20/2009	$3,835.00
Innovation in Weight Management: Novel ingredients, regulatory challenges and go-to-market strategies By: Business Insights Innovation in Weight Management Novel ingredients, regulatory challenges and go-to-market strategies Report Overview... Despite the current economic crisis, the weight management market will continue to expand in line with increasing levels of obesity worldwide. A surge in regulatory \| more... Search inside this report	4/16/2009	$2,875.00
Trends in Unified Communications: Vendor strategies, competitor landscape and market forecasts By: Business Insights Trends in Unified Communications Vendor strategies, competitor landscape and market forecasts Report Overview Unified Communications (UC) is an opportunity for enterprises to revolutionize their work processes, increase efficiency and reduce human latency. In an environment where communications are \| more... Search inside this report	4/7/2009	$2,875.00
The Top 10 Spirits Companies: Industry trends and growth strategies of leading players By: Business Insights The Top 10 Spirits Companies: Industry trends and growth strategies of leading players The global spirits market was worth $216bn in 2007, a 2.4% growth over 2006. The global spirits market is expected to grow at \| more... Search inside this report	4/6/2009	$2,875.00
The Autoimmune Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities By: Business Insights The Autoimmune Market Outlook to 2013 provides comprehensive coverage of the autoimmune market, incorporating disease overviews and detailed epidemiological analyses for the major indications. This report makes a comprehensive assessment of the marketed product portfolio, \| more...	4/1/2009	$3,835.00
Early Stage Drug Safety Strategies and Risk Management: Maximizing opportunities towards achieving clinical success By: Business Insights Declining industrial productivity has forced companies to urgently address the areas of drug development that are most likely to lead to the failure of a new compound. Innovations are required that can support the earlier \| more... Search inside this report	4/1/2009	$3,835.00
Key Players in Pharmaceutical Contract Manufacturing: Market developments, outsourcing hotspots and growth strategies By: Business Insights The pharmaceutical contract manufacturing (PCM) industry continues to grow at a steady pace, driven by cost pressures, stringent regulatory requirements and patent expiries. The highly competitive nature of the industry has been driving consolidation and \| more... Search inside this report	3/23/2009	$3,835.00
The Evolution of Organic Food and Drinks: Growth opportunities, NPD and the impact of the economic downturn By: Business Insights The Evolution of Organic Food and Drinks Growth opportunities, NPD and the impact of the economic downturn Report Overview... The organic food and drinks market grew rapidly over the first part of the decade, with sales in \| more...	3/23/2009	$2,875.00
The Asian Cardiovascular Market Outlook to 2014: Regional and therapeutic analysis, pipeline impact and growth opportunities By: Business Insights The Asian cardiovascular market demonstrated robust sales, unlike the global market which has begun to slow down due to patent expiries of class leading products and strong generic competition. The emerging ten Asian markets analyzed \| more... Search inside this report	3/22/2009	$3,835.00
The Canadian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeline analysis, growth opportunities By: Business Insights This report provides comprehensive coverage of the Canadian market, incorporating an overview of the country, its socioeconomic status and the epidemiological scenario of major pathophysiological disorders. Furthermore, the report analyzes the scenario in Canada pertaining \| more... Search inside this report	3/20/2009	$3,835.00
The Top 10 Contract Research Organizations: Positioning, performance and SWOT analyses By: Business Insights The Top 10 Contract Research Organizations: Positioning, performance and SWOT analyses Cost containment and regulatory pressures within the pharma industry are driving R&D outsourcing across the globe. Clinical obstacles to approval have become more significant due \| more... Search inside this report	3/16/2009	$3,835.00
The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery By: Business Insights The Future of Biobanks: Regulation, ethics, investment and the humanization of drug discovery Report Overview Biobanks collect and store human biospecimens, playing a vital role in the development of novel drugs and diagnostics. In recent years, large \| more... Search inside this report	3/9/2009	$3,835.00
Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors By: Business Insights Evolving Trends in Biopharmaceutical Licensing: Deal assessments, drivers and resistors Large Pharma companies have become heavily dependant upon alliances and in-licensing to gain access to technologies/new molecular entities from Biopharma. This reliance has strengthened \| more... Search inside this report	3/1/2009	$3,835.00
Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROI By: Business Insights Key Trends in Offshoring Pharmaceutical R&D: Company strategies, emerging markets and impact on ROIs Offshoring and outsourcing have become an increasingly critical contributor to pharma and biotech R&D strategies in recent years. They enable \| more... Search inside this report	3/1/2009	$3,835.00
The Top Ten Global In-Vitro Diagnostics Companies: Positioning, performance and SWOT analyses By: Business Insights The Top 10 Global In-Vitro Diagnostics Companies: Positioning, performanceand SWOT analyses The in-vitro diagnostics (IVD) market continues to grow at a steady pace, driven by new fields such as molecular diagnostics and a growing \| more... Search inside this report	3/1/2009	$3,835.00
The Scandinavian Pharmaceutical Market Outlook to 2013: Policy environment, market structure, pipeline analysis, growth opportunities By: Business Insights The Scandinavian Pharma Market Outlook to 2013: Policy environment, market structure, pipeline analysis and growth opportunities The Scandinavian healthcare system and pharmaceutical market is well regulated, with the state bearing responsibility for a large proportion of \| more... Search inside this report	3/1/2009	$3,835.00
Fighting the Market Slowdown in Alcoholic Drinks: Growth hotspots, innovation and changing consumer preferences By: Business Insights Fighting the Market Slowdown in Alcoholic Drinks - Growth hotspots, innovation and changing consumer preferences \| more... Search inside this report	2/25/2009	$2,875.00
The Future of Software Delivery: The opportunities and challenges of emerging software delivery models By: Business Insights The Future of Software Delivery The opportunities and challenges of emerging software delivery models Report Overview The way companies perceive and purchase their software is starting to change. Organizations no longer have to buy \| more... Search inside this report	2/4/2009	$2,875.00
Technology Transfer Strategies: Maximizing The Returns From New Technologies By: Business Insights Report Overview Technology transfer is a long-established part of early-stage research within the pharmaceutical and biotechnology industries. Although technology transfer offices have traditionally been associated with inefficiency and a lack of commercial judgment, recent \| more...	2/1/2009	$3,835.00
The Future of Electrical Energy Storage: The economics and potential of new technologies By: Business Insights Electrical energy storage (apart from pumped storage hydropower) is still a peripheral part of the power generation infrastructure. However, the advancing use of renewable energy, particularly wind power, will change the perception of storage and \| more...	2/1/2009	$2,875.00
The Top 10 Food and Drinks Ingredient Companies: Emerging opportunities, growth strategies and innovation in the leading players By: Business Insights Report Overview The global food and drinks market was worth $3,498bn in 2007, up 3.1% over 2006. The global food and drinks market is anticipated to grow at a CAGR of 3.2% during 2007-10 \| more... Search inside this report	2/1/2009	$2,875.00
Negotiating the Emerging Biosimilars Landscape: Key Developments in the Regulatory Environment By: Business Insights As regulatory obstacles to biosimilars development have become increasingly resolved, a growing number of opportunities have been created for generics companies in the biopharmaceutical market, which according to IMS data was valued at $85.9 billion \| more...	2/1/2009	$3,835.00
The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis By: Business Insights The Cardiovascular Market Outlook to 2013 The cardiovascular therapy area spans a range of treatment classes including anti-hypertensives, anti-dyslipidemics, anti-thrombotics, hematological preparations and cardiac therapies. Each sub-therapy area is facing a different set of \| more... Search inside this report	1/1/2009	$3,835.00
Title	Published	Price

< prev 1 2 3 4 5 6 7 8 9 10 next >

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/24/2009 - 4